Silver and its application as an antimicrobial agent

Expert Opinion on Therapeutic Patents

Volumn 15, Issue 2, 2005, Pages 125-130

  Melaiye, Abdulkareem ^a   Youngs, Wiley J ^a  

^a UNIVERSITY OF AKRON   (United States)

Author keywords

Antifungal; Antiviral; Bactericidal; Nanocrystalline silver; Silver ion

Indexed keywords

ACTICOAT; ACTISORB 220; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBOXYLIC ACID; COLLARGOL; CROTONIC ACID DERIVATIVE; CURAD SILVER; DISINFECTANT AGENT; DNA; ENROFLOXACIN; MAFENIDE; MATRIX METALLOPROTEINASE; METICILLIN; NANOPARTICLE; PENICILLIN G; POLYACRYLIC ACID; POVIDONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA; SILVER; SILVER DERIVATIVE; SILVER ION; SILVER LACTATE; SILVER NITRATE; SUCRALFATE; SULFADIAZINE SILVER; SULFONAMIDE; TETRA SILVER TETRA OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARGYRIA; BLOOD CLOTTING; BREAST CANCER; CLINICAL TRIAL; DIGESTIVE SYSTEM ULCER; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EXCRETION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SUBSTITUTION; EAR INFECTION; ECZEMA; EDITORIAL; ELECTROLYTE DISTURBANCE; FOOT ULCER; HUMAN; INFECTION; IRRITABILITY; LEUKOPENIA; MEDICAL TECHNOLOGY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN OPHTHALMIA; PATENT; PSEUDOMONAS AERUGINOSA; SKIN DISCOLORATION; STRUCTURE ANALYSIS; SURGICAL INFECTION; WOUND DRESSING;

EID: 14544267112     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.15.2.125     Document Type: Editorial

References (39)

1. WAN AT, CONYERS RA, COOMBS CJ, MASTERTON JP: Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin. Chem. (1991) 37(10):1683-1687.
2. LANSDOWN AB: Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. Crit. Rev. Toxicol. (1995) 25(5):397-462.
3. WHITE RJ: An historical overview on the use of silver in modern wound management. Br. J. Nurs. (2002) 15(10):3-8.
4. RUSSELL AD, PATH FR, HUGO WB: Antimicrobial activity and action of silver. Prog. Med. Chem. (1994) 31:351-370.
5. ALBRIGHT CF, NACHUM R, LECHTMAN MD: Electrolytic silver ion generator for water sterilization in Apollo spacecraft water systems. Apollo applications program. NASA Contract Rep. (1967).
6. + alters cell growth, neurite extension, cardiomyocyte beating, and fertilized egg constriction. Aviat. Space Environ. Med. (1999) 70(11):1096-1105.
7. GIBBS RJ: Silver Colloids - Do they work? R Gibbs publisher (privately published); ISBN: 0967699207 (1999).
8. HILL JW: Colloidal silver: a literature review (Chapter 1). In: Medical Uses, Toxicology and Manufacture. 2nd Ed., Clear spring press, Rainer, Washington (2000).
9. LANSDOWN AB: Silver I: its antibacterial properties and mechanism of action. J. Wound Care (2002) 2(4):125-130.
10. KLASEN HJ: Historical review of the use of silver in the treatment of burns. I. Early uses. Burns (2000) 26 2):117-130.
11. KLASEN HJ: A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns (2000) 26:131-138.
12. MOYER CA, BRENTANO L, GRAVENS DL, MARGRAF HW, MONAFO WW: Treatment of large human burns with 0.5% silver nitrate solution. Arch. Surg. (1965) 90:812-867.
13. FOX CL: Silver sulphadiazine: a new topical therapy for pseudomonas in burns. Arch. Surg. (1968) 96:184-188.
14. GUPTA A, MAYNES M, SILVER S: The effect of halides on plasmid silver resistance in Escherichia coli. Appl. Environ. Microbiol. (1998) 64(12):5042-5045.
15. BURRELL RE: A scientific perspective on the use of topical silver preparations. Ostomy Wound Manage. (2003) 49 Suppl.5A):19-24.
16. WRIGHT JB, HANSEN DL, BURRELL RE: The comparative efficacy of two antimicrobial barrier dressings: in vitro examination of two controlled release silver dressings. Wounds (1998) 10 6):179-188.
17. SILVER S: Bacterial silver resistance: molecular biology and uses and misuse of silver compounds. FEMS Microbiol. Rev. (2003) 27:341-353.
18. STARODUB ME, TREVORS JT: Silver resistance in Escherichia coli R1. J. Med. Microbiol. (1989) 29:101-110.
19. FURR JR, RUSSELL AD, TURNER AD, ANDREWS A: Antimicrobial activity of Actisorb Plus, Actisorb and silver nitrate. J. Hosp. Infect. (1994) 27:201-208.
20. THOMAS S, McCUBBIN P: A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J. Wound Care (2003) 12:1011-1017.
21. THOMAS S, McCUBBIN P: An in vitro anaylsis of the antimicrobial properties of 10 silver containing dressings. J. Wound Care (2003) 12:305-308.
22. BALLARD K, McGREGOR F: Avance: silver hydropolymer dressing for critically colonized wounds. Br. J. Nurs. (2002) 11 206-211.
23. GUPTA A, MATSUI K, LO JF, SILVER S: Molecular basis for resistance to silver cations in Salmonella. Nat. Med. (1999) 5 183-188.
24. NIES DH: Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol. Rev. (2003) 27:313-339.
25. AOYAMA H, YOKOO K, FUJII K: Systemic absorption of silver sulphadiazine and sodium sulphadiazine through human wounds. Burns (1990) 16:163-165.
26. LANSDOWN AB, SAMPSON B, ROWE A: Sequential changes in trace metal, metallothionein and calmodulin concentrations in healing skin wounds. J. Anat. (1999) 195:375-386.
27. SAWHINEY CP, SHARMA RK, RAO KR, KAUSHISH R: Long-term experience with silver sulphadiazine cream in the management of burn wounds. Burns (1989) 15:403-406.
28. LEE SM, LEE SH: Generalized argyeria after habitual use of silver nitrate. J. Dermatol. (1994) 21:50-3.
29. HOLLINGER MA: Toxicological aspects of topical silver pharmaceuticals. Crit. Rev. Toxicol. (1996) 26:255-60.
30. LEIDBERG H, LUNDEBERG T: Assessment of silver coated urinary catheter toxicity by cell culture. Urological Res. (1989) 17 359-360.
31. MCCAULEY RL, LINARES HA, PELLIGRINI V, HERNDON DN, ROBSON MC, HEGGERS JP: In vitro toxicity of topical antimicrobial agents to human fibroblasts. J. Surg. Res. (1989) 46:267-274
32. MCCAULEY RL, LI YY, POOLE B et al.: Differential inhibition of human basal keratinocyte growth to silver sulphadiazine and mafenate acetate. J. Surg. Res. (1992) 52:276-285.
33. LEITCH IO, KUCUKCELEBI A, ROBSON MC: Inhibition of wound contraction by topical antibacterials. Aust. NZ J. Surg. (1993) 63:289-93.
34. JARRETT F, ELLERBE S, DEMLING R: Acute leucopenia during topical burn therapy with silver sulphadiazine. Am. J. Surg. (1978) 135:818-819.
35. LANSDOWN AB: Silver 2: toxicity in mammals and how its products aid wound repair. J. Wound Care (2002) 11 5):173-177.
36. HILLS WR, PILLSBURY DM: Argyria. The pharmacology of silver. Bailliere Tindall and Cox, London (1939).
37. DEMLING RH, DISANTI L: Effects of silver wound management. Wounds (2001) 13(Suppl.A):5-15.
38. GOVAN JR, DERETIC V: Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. (1996) 60(3):539-574.
39. SIBBALD RG: Infection control, is it the needed to prepare the wound bed? The clinical relevance of wound bed preparation. Paper presented at the 11th Annual Meeting of the European Tissue Repair Society, Cardiff (2001).